Discovery of A-910, a Highly Potent and Orally Bioavailable Dual MerTK/Axl-Selective Tyrosine Kinase InhibitorYi‐Yun Yu, Michael R. Michaelides, Yujia Dai et al.|Journal of Medicinal Chemistry|2024Cited by 8
Discovery of Potent Azetidine-Benzoxazole MerTK Inhibitors with <i>In Vivo</i> Target EngagementRobin R. Frey, Thomas D. Penning, Navendu Jana et al.|Journal of Medicinal Chemistry|2024Cited by 6
Abstract B098: An integrated fragment approach yields ABBV-973, a potent, pan-allele small molecule STING agonist for intravenous administrationKenneth D. Bromberg, Andrew S. Judd, Douglas E. Kline et al.|Cancer Immunology Research|2025Cited by 0